Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Frederic Colombel

Showing results (291-300 of 377) with videos related to

Pageof 38
Sort By:
The New England Journal of Medicine|May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's DiseaseEdward V Loftus, Julian Panés, Ana P Lacerda, et al.
Journal of Crohn'S & Colitis|August 31, 2023
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label ExtensionSilvio Danese, Remo Panaccione, Maria T Abreu, et al.
Inflammatory Bowel Diseases|March 11, 2019
Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel DiseaseRobert P Hirten, Ari Grinspan, Shih-Chen Fu, et al.
Gastroenterology|August 20, 2013
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONICMarc Ferrante, Jean-Frederic Colombel, William J Sandborn, et al.
Journal of Crohn'S & Colitis|November 24, 2020
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD RegistryManasi Agrawal, Erica J Brenner, Xian Zhang, et al.
Journal of Inflammation Research|November 24, 2025
Association Between Maternal IBD-Related Antibodies and Early Life Gut Inflammatory Status and Microbiota Composition: Insights from Cord BloodTaegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Maternal IBD-related antibodies are associated with early life gut inflammatory status and microbiota composition: insights from cord bloodTaegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Gastroenterology|December 28, 2020
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDDan Turner, Amanda Ricciuto, Ayanna Lewis, et al.
Gastroenterology|December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's DiseaseJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Crohn'S & Colitis 360|March 21, 2022
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel DiseaseQuazim A Alayo, Marc Fenster, Osama Altayar, et al.
Pageof 38

Showing results (291-300 of 377) with videos related to

Sort By:
Pageof 38
The New England Journal of Medicine|May 24, 2023
Upadacitinib Induction and Maintenance Therapy for Crohn's DiseaseEdward V Loftus, Julian Panés, Ana P Lacerda, et al.
Journal of Crohn'S & Colitis|August 31, 2023
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label ExtensionSilvio Danese, Remo Panaccione, Maria T Abreu, et al.
Inflammatory Bowel Diseases|March 11, 2019
Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel DiseaseRobert P Hirten, Ari Grinspan, Shih-Chen Fu, et al.
Gastroenterology|August 20, 2013
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONICMarc Ferrante, Jean-Frederic Colombel, William J Sandborn, et al.
Journal of Crohn'S & Colitis|November 24, 2020
Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD RegistryManasi Agrawal, Erica J Brenner, Xian Zhang, et al.
Journal of Inflammation Research|November 24, 2025
Association Between Maternal IBD-Related Antibodies and Early Life Gut Inflammatory Status and Microbiota Composition: Insights from Cord BloodTaegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Maternal IBD-related antibodies are associated with early life gut inflammatory status and microbiota composition: insights from cord bloodTaegyu Kim, Paola Nicoletti, Maria Manuela Estevinho, et al.
Gastroenterology|December 28, 2020
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDDan Turner, Amanda Ricciuto, Ayanna Lewis, et al.
Gastroenterology|December 27, 2017
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's DiseaseJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Crohn'S & Colitis 360|March 21, 2022
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel DiseaseQuazim A Alayo, Marc Fenster, Osama Altayar, et al.
Pageof 38